Summary:
Click image to enlarge
Are you experiencing moderate to severe acne?
We are conducting a clinical research study to evaluate the safety and efficacy of a potential acne mRNA vaccine. An acne vaccine is a new type of treatment being researched that aims to prevent or reduce acne by targeting the bacteria and inflammation that cause it. Unlike traditional acne treatments like creams or antibiotics, an acne vaccine works by stimulating your immune system to fight the bacteria Cutibacterium acnes (formerly Propionibacterium acnes), which contributes to acne development. Instead of just treating symptoms, the vaccine could potentially provide longer-lasting protection by reducing the bacteria’s ability to cause inflammation and breakouts. Many acne vaccines currently under study use mRNA technology or protein-based approaches to teach the immune system how to respond more effectively.
Qualified Participants Must:
• Adults ages 18–45
•
Diagnosed with moderate to severe acne vulgaris
Qualified Participants May Receive:
- Get paid: Receive up to $100 per clinic visit — with zero cost to you or your insurance.
- Expert care: Regular check-ins and health assessments with dedicated healthcare professionals.
- No-cost treatment: Study vaccines and related care provided at no cost.